The DOI matches its Crossref record; 292 of the 292 references it cites were found in a registry or an index.
Consensus guidelines for the detection of immunogenic cell death
Open accessAbstract
and to screen large chemical libraries for putative ICD inducers, based on a high-content, high-throughput platform that we recently developed. Such a platform allows for the detection of multiple DAMPs, like cell surface-exposed calreticulin, extracellular ATP and high mobility group box 1 (HMGB1), and/or the processes that underlie their emission, such as endoplasmic reticulum stress, autophagy and necrotic plasma membrane permeabilization. We surmise that this technology will facilitate the development of next-generation anticancer regimens, which kill malignant cells and simultaneously convert them into a cancer-specific therapeutic vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunogenic cell death (ICD) is a functionally peculiar form of RCD that is sufficient to activate an adaptive immune response specific for endogenous (cellular) or exogenous (viral) antigens expressed by dying cells [852, 853].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [853]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–292 of 292
A Systematic Nomenclature for the Redox States of High Mobility Group Box (HMGB) Proteins
Antoine, D. J., Harris, H. E., Andersson, U., Tracey, K. J., & Bianchi, M. E. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00022 · Cited by 108
Sukkurwala, A. Q., Martins, I., Wang, Y., Schlemmer, F., Ruckenstuhl, C., Durchschlag, M., Michaud, M., Senovilla, L., Sistigu, A., Ma, Y., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.73 · Cited by 108
Self-citationVatakis, D. N., Koya, R. C., Nixon, C. C., Liu, W., Kim, S. G., Avancena, P., Bristol, G. C., Baltimore, D., Kohn, D. B., Ribas, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115050108 · Cited by 108
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death
Martins, I., Michaud, M., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Shen, S., Kepp, O., Menger, L., Vacchelli, E., Galluzzi, L., et al. (2012) · Autophagy · doi:10.4161/auto.19009 · Cited by 107
Self-citationCombination of glycolysis inhibition with chemotherapy results in an antitumor immune response
Bénéteau, M., Zunino, B., Jacquin, M. A., Meynet, O., Chiche, J., Pradelli, L. A., Marchetti, S., Cornille, A., Carlès, M., & Ricci, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206360109 · Cited by 106
Self-citationThe emergence of phox-ER stress induced immunogenic apoptosis
Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2012) · OncoImmunology · doi:10.4161/onci.19750 · Cited by 106
Self-citationRelease of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity
Candolfi, M., Yagiz, K., Foulad, D. S., Alzadeh, G. E., Tesarfreund, M., Muhammad, A. K. M. G., Puntel, M., Kroeger, K. M., Liu, C., Lee, S. C. L., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0155 · Cited by 106
Self-citationEricsson, J. (1969) · Experimental Cell Research · doi:10.1016/0014-4827(69)90030-5 · Cited by 105
Hoffmann, J., Vitale, I., Buchmann, B., Galluzzi, L., Schwede, W., Senovilla, L., Skuballa, W., Vivet, S., Lichtner, R. B., Vicencio, J. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0237 · Cited by 103
Self-citationSchildkopf, P., Frey, B., Ott, O. J., Rubner, Y., Multhoff, G., Sauer, R., Fietkau, R., & Gaipl, U. S. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.056 · Cited by 101
Self-citationMa, Y., Adjemian, S., Yang, H., Catani, J. P. P., Hannani, D., Martins, I., Michaud, M., Kepp, O., Sukkurwala, A. Q., Vacchelli, E., et al. (2013) · OncoImmunology · doi:10.4161/onci.24568 · Cited by 97
Self-citationVacchelli, E., Vitale, I., Tartour, É., Eggermont, A. M. M., Sautès‐Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.25595 · Cited by 95
Self-citationPol, J. G., Bloy, N., Obrist, F., Eggermont, A. M. M., Galon, J., Cremer, I., Erbs, P., Limacher, J., Préville, X., Zitvogel, L., et al. (2014) · OncoImmunology · doi:10.4161/onci.28694 · Cited by 94
Self-citationImmune-related gene signatures predict the outcome of neoadjuvant chemotherapy
Stoll, G., Enot, D. P., Mlecnik, B., Galon, J., Zitvogel, L., & Kroemer, G. (2014) · OncoImmunology · doi:10.4161/onci.27884 · Cited by 92
Self-citationHMGB1 as an autophagy sensor in oxidative stress
Kang, R., Livesey, K. M., Zeh, H. J., et al. (2011) · Autophagy · doi:10.4161/auto.7.8.15704 · Cited by 91
Garrido, G., Rabasa, A., Sánchez, B., López, M. V., Blanco, R., López, A., Hernández, D. R., Pérez, R., & Fernández, L. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003477 · Cited by 91
Kenis, H., Zandbergen, H. R., Hofstra, L., Petrov, A. D., Dumont, E. A. W. J., Blankenberg, F. G., Haider, N., Bitsch, N. J. J. E., Gijbels, M. J., Verjans, J. W. H., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.068429 · Cited by 90
Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens
Ladoire, S., Chaba, K., Martins, I., Sukkurwala, A. Q., Adjemian, S., Michaud, M., Poirier-Colame, V., Andreiuolo, F. D. M., Galluzzi, L., White, E., et al. (2012) · Autophagy · doi:10.4161/auto.20353 · Cited by 88
Self-citationRadiation induces an antitumour immune response to mouse melanoma
Perez, C. A., Fu, A., Onishko, H. M., Hallahan, D. E., & Geng, L. (2009) · International Journal of Radiation Biology · doi:10.3109/09553000903242099 · Cited by 88
Aranda, F., Vacchelli, E., Obrist, F., Eggermont, A. M. M., Galon, J., Sautès‐Fridman, C., Cremer, I., ter Meulen, J. H., Zitvogel, L., Kroemer, G., et al. (2014) · OncoImmunology · doi:10.4161/onci.29179 · Cited by 85
Self-citationCirone, M., Renzo, L. D., Lotti, L. V., Conte, V., Trivedi, P., Santarelli, R., Gonnella, R., Frati, L., & Faggioni, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031732 · Cited by 85
Self-citationKohles, N., Nagel, D., Jüngst, D., Stieber, P., & Holdenrieder, S. (2012) · Tumor Biology · doi:10.1007/s13277-012-0504-2 · Cited by 85
Self-citationStoetzer, O. J., Fersching, D. M. I., Salat, C., Steinkohl, O., Gabka, C. J., Hamann, U., Braun, M., Feller, A. M., Heinemann, V., Siegele, B., et al. (2012) · Tumor Biology · doi:10.1007/s13277-012-0513-1 · Cited by 85
Self-citationAguilera, R., Saffie, C., Tittarelli, A., González, F. E., Ramírez, M., Reyes, D., Pereda, C., Hevia, D., García‐Salum, T., Salazar, L., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2384 · Cited by 84
Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis
Perné, A., Muellner, M. K., Steinrueck, M., Craig-Mueller, N., Mayerhofer, J., Schwarzinger, I., Sloane, M. A., Uras, I. Z., Hoermann, G., Nijman, S. M. B., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008292 · Cited by 82
Yang, Y., Li, X.-J., Chen, Z., Zhu, X.-X., Wang, J., Zhang, L., Qiang, L., Ma, Y., Li, Z., Guo, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050811 · Cited by 80
Self-citationAngelova, A. L., Grekova, S. P., Heller, A., Kuhlmann, O., Soyka, E., Giese, T., Aprahamian, M., Bour, G., Rüffer, S., Cziepluch, C., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03688-13 · Cited by 76
Self-citationFirefly and bacterial luminescence: basic science and applications.
Wd, M., & Ma, D. (1983) · PubMed · Cited by 76
Huang, B., Sikorski, R. P., Kirn, D. H., & Thorne, S. H. (2010) · Gene Therapy · doi:10.1038/gt.2010.121 · Cited by 76
Self-citationSubversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
Michaud, M., Sukkurwala, A. Q., Martins, I., Shen, S., Zitvogel, L., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.19070 · Cited by 74
Self-citationLavieri, R., Piccioli, P., Carta, S., Delfino, L., Castellani, P., & Rubartelli, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303480 · Cited by 72
Self-citationD’Eliseo, D., Manzi, L., & Velotti, F. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0422-2 · Cited by 72
Self-citationFrom regulation of dying cell engulfment to development of anti-cancer therapy
Krysko, D. V., & Vandenabeele, P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402271 · Cited by 71
Self-citationWorkenhe, S. T., Pol, J. G., Lichty, B. D., Cummings, D. T., & Mossman, K. L. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0059-t · Cited by 71
Self-citationImmune-cell lineage commitment: translation from mice to humans.
Payne, K., & Crooks, G. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.011 · Cited by 70
Select forms of tumor cell apoptosis induce dendritic cell maturation
Demaria, S., Santori, F. R., Ng, B., Liebes, L., Formenti, S. C., & Vukmanović, S. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804478 · Cited by 67
Self-citationAntineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia
Tailler, M., Senovilla, L., Lainey, É., Thépot, S., Métivier, D., Sébert, M., Baud, V., Billot, K., Fenaux, P., Galluzzi, L., et al. (2011) · Oncogene · doi:10.1038/onc.2011.521 · Cited by 67
Self-citationTargeting tumors with LIGHT to generate metastasis-clearing immunity
Yu, P., & Fu, Y. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.004 · Cited by 66
Wittwer, C., Boeck, S. H., Heinemann, V., Haas, M., Stieber, P., Nagel, D., & Holdenrieder, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28294 · Cited by 66
Self-citationBak and Bax are non‐redundant during infection‐ and DNA damage‐induced apoptosis
Kepp, O., Rajalingam, K., Kimmig, S., & Rudel, T. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601533 · Cited by 63
Self-citationHigh Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
Aliagas, E., Vidal, A., Texidó, L., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/509027 · Cited by 59
Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis
Urbonaviciute, V., Meister, S., Fürnrohr, B. G., Frey, B., Gückel, E., Schett, G. A., i, M. H., & Voll, R. E. (2009) · Autoimmunity · doi:10.1080/08916930902831803 · Cited by 57
Chemotherapy Induces Tumor Clearance Independent of Apoptosis
Guerriero, J. L., Ditsworth, D., Fan, Y., Zhao, F., Crawford, H. C., & Zong, W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2452 · Cited by 57
Self-citationGarg, A. D., Dudek, A. M., & Agostinis, P. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.372 · Cited by 57
Self-citationImmunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma
Tongu, M., Harashima, N., Yamada, T., Harada, T., & Harada, M. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0797-1 · Cited by 56
Chen, X., Yang, Y.-A., Zhou, Q., Weiss, J. M., Howard, O. Z., McPherson, J. M., Wakefield, L. M., & Oppenheim, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085398 · Cited by 55
Xiang, Y., Wang, X., Yan, C., Gao, Q., Li, S., Liu, J., Zhou, K., Guo, X., Lee, W., & Zhang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063759 · Cited by 55
The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy
Ghiringhelli, F., & Apétoh, L. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.865520 · Cited by 54
Self-citationPauleau, A.-L., Larochette, N., Giordanetto, F., Scholz, S. R., Poncet, D., Zamzami, N., Goldmacher, V. S., & Kroemer, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210511 · Cited by 53
Self-citationCirone, M., Garufi, A., Renzo, L. D., Granato, M., Faggioni, A., & D’Orazi, G. (2013) · OncoImmunology · doi:10.4161/onci.26198 · Cited by 52
Self-citationCell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity
Ladoire, S., Hannani, D., Vétizou, M., Locher, C., Aymeric, L., Apétoh, L., Kepp, O., Kroemer, G., Ghiringhelli, F., & Zitvogel, L. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5133 · Cited by 50
Self-citationChemo-Immunotherapy with Oxaliplatin and Interleukin-7 Inhibits Colon Cancer Metastasis in Mice
Gou, H., Huang, J., Shi, H., Chen, X.-C., & Wang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085789 · Cited by 50
Brusa, D., Migliore, E., Garetto, S., Simone, M., & Matera, L. (2009) · The Prostate · doi:10.1002/pros.20981 · Cited by 48
Activation of dendritic cells by tumor cell death
Cirone, M., Renzo, L. D., Lotti, L. V., et al. (2012) · OncoImmunology · doi:10.4161/onci.20428 · Cited by 47
Self-citationBruserud, Ï. ⁄. Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1229 · Cited by 47
Taming Dendritic Cells with TIM-3: Another Immunosuppressive Strategy Used by Tumors
Patel, J. M., Bozeman, E. N., & Selvaraj, P. (2012) · Immunotherapy · doi:10.2217/imt.12.126 · Cited by 45
Garg, A. D., Dudek, A. M., & Agostinis, P. (2013) · OncoImmunology · doi:10.4161/onci.26260 · Cited by 42
Self-citationCapsaicin-mediated apoptosis of human bladder cancer cells activates dendritic cells via CD91
Montani, M. S. G., D’Eliseo, D., Cirone, M., et al. (2014) · Nutrition · doi:10.1016/j.nut.2014.05.005 · Cited by 41
Self-citationClearance of dead cells: mechanisms, immune responses and implication in the development of diseases
Krysko, D. V., & Vandenabeele, P. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0524-6 · Cited by 39
Self-citationMineharu, Y., King, G. D., Muhammad, A. G., Bannykh, S., Kroeger, K. M., Liu, C., Lowenstein, P. R., & Castro, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0915 · Cited by 39
Self-citationPathak, S. K., Sköld, A. E., Mohanram, V., Persson, C. M., Johansson, U., & Spetz, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336545 · Cited by 39
Impact of myeloid cells on the efficacy of anticancer chemotherapy
Senovilla, L., Aranda, F., Galluzzi, L., & Kroemer, G. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.05.009 · Cited by 39
Self-citationShaping developing tissues by apoptosis
Abud, H. E. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401455 · Cited by 38
Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy
Emeagi, P. U., Lint, S. V., Goyvaerts, C., Maenhout, S. K., Cauwels, A., McNeish, I. A., Bos, T. J., Heirman, C., Thielemans, K., Aerts, J. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2400 · Cited by 37
Self-citationMellén, M., de la Rosa, E. J., & Boya, P. (2009) · Autophagy · doi:10.4161/auto.5.7.9292 · Cited by 34
STUDIES ON THE CHANGES PRODUCED BY ROENTGEN RAYS IN INFLAMED CONNECTIVE TISSUE
Maximow, A. A. (1923) · The Journal of Experimental Medicine · doi:10.1084/jem.37.3.319 · Cited by 34
Plasma HMGB ‐1 after the initial dose of epirubicin/docetaxel in cancer
Arnold, T., Michlmayr, A., Baumann, S., Burghuber, C. K., Pluschnig, U., Bartsch, R., Steger, G. G., Gnant, M., Bergmann, M. M., Bachleitner‐Hofmann, T., et al. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12043 · Cited by 33
Self-citationA human autophagy interaction network
Klionsky, D. J. (2012) · Autophagy · doi:10.4161/auto.19926 · Cited by 32
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells
Paroli, M., Bellati, F., Videtta, M., Focaccetti, C., Mancone, C., Donato, T., Antonilli, M., Perniola, G., Accapezzato, D., Napoletano, C., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28515 · Cited by 32
Self-citationKorbelik, M., Banáth, J. P., Sun, J., et al. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.03.016 · Cited by 30
Self-citationGalluzzi, L., Vitale, I., Kepp, O., Séror, C., Hangen, E., Perfettini, J., Modjtahedi, N., & Kroemer, G. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01418-3 · Cited by 29
Self-citationSonnemann, J., Greßmann, S., Becker, S., Wittig, S., Schmudde, M., & Beck, J. F. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1302-4 · Cited by 29
Self-citationEx vivo– and in vivo–induced dead tumor cells as modulators of antitumor responses
Weiss, E., Frey, B., Rödel, F., i, M. H., Schlücker, E., Voll, R. E., Fietkau, R., & Gaipl, U. S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05743.x · Cited by 28
Self-citationTherapeutic Implications of Immunogenic Cell Death in Human Cancer
Palombo, F., Focaccetti, C., & Barnaba, V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00503 · Cited by 28
Self-citationRewiring cancer cell death to enhance oncolytic viro-immunotherapy
Workenhe, S. T., & Mossman, K. L. (2013) · OncoImmunology · doi:10.4161/onci.27138 · Cited by 27
Self-citationStoetzer, O. J., Wittwer, C., Lehner, J., Fahmueller, Y. N., Kohles, N., Fersching, D. M. I., Leszinski, G. S., Roessner, J., & Holdenrieder, S. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.689280 · Cited by 27
Self-citationMolinari, R., D’Eliseo, D., Manzi, L., Zolla, L., Velotti, F., & Merendino, N. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1074-7 · Cited by 25
Self-citationEpothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells
Pellicciotta, I., Yang, C. H., Goldberg, G. L., et al. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.05.007 · Cited by 24
Riganti, C., & Massaia, M. (2013) · OncoImmunology · doi:10.4161/onci.25770 · Cited by 24
Self-citationMelis, M. H. M., Simpson, K., Dovedi, S. J., Welman, A., MacFarlane, M., Dive, C., Honeychurch, J., & Illidge, T. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.8 · Cited by 23
Self-citationZirger, J. M., Puntel, M., Bergeron, J., Wibowo, M., Moridzadeh, R. S., Bondale, N. S., Barcia, C., Kroeger, K. M., Liu, C., Castro, M. G., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2011.243 · Cited by 20
Self-citationFluorescent Biosensors for the Detection of HMGB1 Release
Martins, I., Kepp, O., Menger, L., Michaud, M., Adjemian, S., Sukkurwala, A. Q., Vacchelli, E., Galluzzi, L., & Kroemer, G. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-383-1_4 · Cited by 19
Self-citationFollowing up tumor-specific regulatory T cells in cancer patients
Zitvogel, L., Tanchot, C., Granier, C., & Tartour, É. (2013) · OncoImmunology · doi:10.4161/onci.25444 · Cited by 18
Self-citationLiljenfeldt, L., Gkirtzimanaki, K., Vyrla, D., et al. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1507-6 · Cited by 18
Predictive immunomonitoring — The COST ENTIRE initiative
Popadic, D. M., Anegón, I., Baeten, D., Eibel, H., Giese, T., Marits, P., Martínez-Cáceres, E. M., Mascart, F., Nestle, F. O., Pujol‐Borrell, R., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.013 · Cited by 15
SEPTACIDIN, A NEW ANTITUMOR AND ANTIFUNGAL ANTIBIOTIC PRODUCED BY STREPTOMYCES FIBRIATUS.
DUTCHER, J. D., Vonsaltza, M. H., & PANSY, F. E. (1963) · PubMed · Cited by 15
Klionsky, D. J. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)03631-8 · Cited by 10
The role of SMAC mimetics in regulation of tumor cell death and immunity
Emeagi, P. U., Thielemans, K., & Breckpot, K. (2012) · OncoImmunology · doi:10.4161/onci.20369 · Cited by 10
Self-citationSynchronous apoptosis in established tumors leads to the induction of adaptive immunity
Honeychurch, J., Dive, C., & Illidge, T. (2013) · OncoImmunology · doi:10.4161/onci.24501 · Cited by 6
Self-citationMitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Olsson, L., & Ebbesen, P. (1978) · PubMed · Cited by 4
Ōmasa, T., Chen, Y., Mantalaris, A., et al. (2002) · DNA sequence · doi:10.1080/10425170290023428 · Cited by 3
Flagged first, then by citations
Research works printed but not linked: 7
- Vogt CI, 1842, Jent
- 10.1038/emboj.2009.1x · DOI
- Dutcher JD, 1963, Antimicrob Agents Chemother (Bethesda), 161, 83
- Olsson L, 1978, Biomedicine, 28, 88
- Fredly H, 2011, Oncol Rep, 25, 1549
- McElroy WD, 1983, J Appl Biochem, 5, 197
- Klionsky DJ, 2009, Methods Enzymol, 452, xxi-xxii
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Self-citationImmunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Self-citationImmunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
Integrating oncolytic viruses in combination cancer immunotherapy
Bommareddy, P. K., Shettigar, M., & Kaufman, H. L. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0014-6 · Cited by 704
Metadata
- Authors
- Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., Bracci, L., Breckpot, K., Brough, D., Buqué, A., Castro, M. G., Cirone, M., Colombo, M. I., Cremer, I., Demaria, S., Dini, L., Eliopoulos, A. G., Faggioni, A., Formenti, S. C., Fučíková, J., Gabriele, L., Gaipl, U. S., Galon, J., Garg, A., Ghiringhelli, F., Giese, N. A., Guo, Z. S., Hemminki, A., Herrmann, M., Hodge, J. W., Holdenrieder, S., Honeychurch, J., Hu, H.-M., Huang, X., Illidge, T. M., Kono, K., Korbelik, M., Krysko, D. V., Loi, S., Lowenstein, P. R., Lugli, E., Ma, Y., Madeo, F., Manfredi, A. A., Martins, I., Mavilio, D., Menger, L., Merendino, N., Michaud, M., Mignot, G., Mossman, K. L., Multhoff, G., Oehler, R., Palombo, F., Panaretakis, T., Pol, J., Proietti, E., Ricci, J.-E., Riganti, C., Rovere-Querini, P., Rubartelli, A., Sistigu, A., Smyth, M. J., Sonnemann, J., Spisek, R., Stagg, J., Sukkurwala, A. Q., Tartour, E., Thorburn, A., Thorne, S. H., Vandenabeele, P., Velotti, F., Workenhe, S. T., Yang, H., Zong, W.-X., Zitvogel, L., Kroemer, G., & Galluzzi, L.
- Affiliations
- Inserm (FR)
- Instituto Nazionale Tumori Regina Elena (IT)
- KU Leuven (BE)
- Istituto Pasteur (IT)
- Istituto Superiore di Sanità (IT)
- Université Libre de Bruxelles (BE)
- University of Manchester (GB)
- University of Michigan (US)
- Sapienza University of Rome (IT)
- New York University (US)
- University of Salento (IT)
- University of Crete (GR)
- NYU Langone Health (US)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University Hospital Heidelberg (DE)
- University of Pittsburgh (US)
- University of Helsinki (FI)
- National Institutes of Health (US)
- University Hospital Bonn (DE)
- Manchester Academic Health Science Centre (GB)
- National University of Singapore (SG)
- BC Cancer Agency (CA)
- Ghent University (BE)
- Peter MacCallum Cancer Centre (AU)
- University of Milan (IT)
- University of Graz (AT)
- Vita-Salute San Raffaele University (IT)
- Université Paris-Sud (FR)
- Università degli Studi della Tuscia (IT)
- McMaster University (CA)
- TUM Klinikum (DE)
- Comprehensive Cancer Center Vienna (AT)
- Karolinska Institutet (SE)
- University of Turin (IT)
- Ospedale Policlinico San Martino (IT)
- The University of Queensland (AU)
- Jena University Hospital (DE)
- Centre Hospitalier de l’Université de Montréal (CA)
- University of Colorado Anschutz (US)
- University of Hawaii Cancer Center (US)
- Stony Brook University (US)
- Corresponding author
- Galluzzi, Lorenzo
- ORCID
- Kepp, Oliver
- Senovilla, Laura
- Vitale, Ilio
- Vacchelli, Erika
- Adjemian, Sandy
- Agostinis, Patrizia
- Aranda, Fernando
- Barnaba, Vincenzo
- Bloy, Norma
- Bracci, Laura
- Breckpot, Karine
- Brough, David
- Buqué, Aitziber
- Castro, Maria G.
- Cirone, Mara
- Cremer, Isabelle
- Demaria, Sandra
- Eliopoulos, Aristides G.
- Faggioni, Alberto
- Formenti, Silvia C.
- Gabriele, Lucia
- Gaipl, Udo S.
- Galon, Jérôme
- Garg, Abhishek
- Ghiringhelli, François
- Giese, Nathalia A.
- Guo, Zong Sheng
- Hemminki, Akseli
- Hodge, James W.
- Holdenrieder, Stefan
- Honeychurch, Jamie
- Huang, Xing
- Illidge, Tim M.
- Kono, Koji
- Korbelik, Mladen
- Krysko, Dmitri V.
- Loi, Sherene
- Lowenstein, Pedro R.
- Lugli, Enrico
- Ma, Yuting
- Madeo, Frank
- Manfredi, Angelo A.
- Martins, Isabelle
- Mavilio, Domenico
- Menger, Laurie
- Merendino, Nicolò
- Mossman, Karen L.
- Multhoff, Gabriele
- Oehler, Rudolf
- Palombo, Fabio
- Panaretakis, Theocharis
- Pol, Jonathan
- Proietti, Enrico
- Ricci, Jean-Ehrland
- Riganti, Chiara
- Rubartelli, Anna
- Sistigu, Antonella
- Smyth, Mark J.
- Stagg, John
- Thorburn, Andrew
- Thorne, Stephen H.
- Vandenabeele, Peter
- Velotti, Francesca
- Workenhe, Samuel T.
- Yang, Haining
- Zitvogel, Laurence
- Kroemer, Guido
- Galluzzi, Lorenzo
- Venue
- OncoImmunology
- Publisher
- Informa UK Limited
- Published
- 2014-09-02
- Volume
- 3
- Issue
- 9
- Pages
- e955691
- ISSN
- 2162-4011 (ISSN-L)
- 2162-402X
- PMC
- PMC4292729
- OpenAlex
- W2163252162
- Cited by
- 832
- References
- 292
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 44 · 2023: 66 · 2022: 77 · 2021: 95 · 2020: 93 · 2019: 95 · 2018: 63 · 2017: 62 · 2016: 83 · 2015: 48 · 2014: 5
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- OncoImmunology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Lirias (submittedVersion, other-oa)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- UnitusOpen (Tuscia University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- AIRUS (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Cancer Research UK (11335, 17737)
- European Commission
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Fondation de France
- Institut National Du Cancer
- National Institutes of Health (5r01ns082311-05)
- Labex Immuno-Oncology
- National Cancer Institute (R01CA129536)
- National Institute of Neurological Disorders and Stroke (R01NS074387, R01NS061107, R01NS057711, R01-NS082311)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- immunogenic cell death, calreticulin exposure, extracellular ATP, HMGB1, endoplasmic reticulum stress, autophagy, cancer immunotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
